Equine pericardium collagen wound dressing in the treatment of the neuropathic diabetic foot wound a pilot study

Journal of the American Podiatric Medical Association

Volumn 99, Issue 4, 2009, Pages 301-305

  Fleischli, John G ^a   Laughlin, Terese J ^a   Fleischli, Jeffery W ^a  

^a Foot and Ankle Associates of Central Illinois LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69549086131     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/0980301     Document Type: Article

References (24)

1. National Institutes of Health. Report of the National Diabetes Advisory Board, p 25, National Institutes of Health, Bethesda, MD, 1980. NIH publication 81:2284.
2. PECORARO RE, REIBER GE, BURGESS EM: Causal pathways to amputation: basis for prevention. Diabetes Care 13: 513, 1990.
3. BREM H, SHEEHAN P, BOULTON AJ: Protocol for treatment of diabetic foot ulcers. Am J Surg 187: IS, 2004.
4. BRIGIDO SA: The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16 week pilot study. Int Wound J 3: 181, 2006.
5. BRIGIDO SA, BOC SF, LOPEZ RC: Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. Orthopedics 27 (suppl): sl45, 2004.
6. EHRENREICH M, RUSZCZAK Z: Tissue-engineered temporary wound coverings: important options for the clinician. Acta Dermatovenerol Alp Panonica Adriat 15: 5, 2006.
7. NIEZGODA JA, VAN GILS CC, FRYKBERG RG, ET AL: Randomized clinical trial comparing OASIS wound matrix to Re- granex Gel for diabetic ulcers. Adv Skin Wound Care 18: 258, 2005.
8. SILVERSTEIN G: Dermal regeneration template in the surgical management of diabetic foot ulcers: a series of five cases. J Foot Ankle Surg 45: 28, 2006.
9. STERN R, MCPHERSON M, LONGAKER M: Histological study of artificial skin used in treatment of full-thickness thermal injury. J Burn Care Rehabil 11: 7, 1990.
10. VEVES A, FALANGA V, ARMSTRONG DG, ET AL: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24: 290, 2001.
11. FLEISCHLI JG, FLEISCHLI JW: Preliminary results of a pilot study evaluating the use of a novel collagen wound dressing for the management of plantar neuropathic foot ulcers. Paper presented at: American College of Foot and Ankle Surgeons Annual Scientific Meeting; March 2007; Orlando, FL.
12. GENTZKOW GD, IWASAKI SD, HERSHON KS, ET AL: Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19: 350, 1996.
13. NATARAJ C, RITTER G, DUMAS S, ET AL: Novel stabilization and sterilization method for collagen-based biologic wound dressings. Wounds 19: 148, 2007.
14. LAVERY LA, ARMSTRONG DG, VELA SV, ET AL: Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 158: 157, 1998.
15. SHEEHAN P, JONES P, CASELLI A, ET AL: Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of compete healing in a 12- week prospective trial. Diabetes Care 26: 1879, 2003.
16. MARSTON WA, HANFT J, NORWOOD P, ET AL: The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26: 1701, 2003.
17. VEVES A, SHEEHAN P, PHAM HT: A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137: 822, 2002.
18. MOSTOW E, HARAWAY G, DALSING M, ET AL: Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vase Surg 41: 837, 2005.
19. WINTERS CL, BRIGIDO SA, LIDEN BA, ET AL: A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Adv Skin Wound Care 21: 375, 2008.
20. MARTIN BR, SANGALANG M, WU S, ET AL: Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience. Int Wound J 2: 161, 2005.
21. ROMANELLI M, DINI V, BERTONE M, ET AL: OASIS wound matrix versus Hyaloskin in the treatment of difficult-to- heal wounds of mixed arterial/venous aetiology. Int Wound J 4: 3, 2007.
22. BRODEN B: Roentgen examination of the subtaloid joint in fractures of the calcaneus. Acta Radiol 31: 85, 1949.
23. BLUME PA, WALTERS J, PAYNE W, ET AL: Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 31: 631, 2008.
24. SACKHEIM K, DE ARAUJO TS, KIRSNER RS: Compression modalities and dressings: their use in venous ulcers. Dermatol Ther 19: 338, 2006.